Literature DB >> 25063780

Increased expression of SAMHD1 in a subset of HIV-1 elite controllers.

Eva Riveira-Muñoz1, Alba Ruiz1, Eduardo Pauls1, Marc Permanyer1, Roger Badia1, Beatriz Mothe1, Manel Crespo2, Bonaventura Clotet1, Christian Brander3, Ester Ballana1, José A Esté4.   

Abstract

OBJECTIVES: SAMHD1 and the CDKN1A (p21) cyclin-dependent kinase inhibitor have been postulated to mediate HIV-1 restriction in CD4+ cells. We have shown that p21 affects HIV replication through its effect on SAMHD1. Thus, we aimed at evaluating the expression of SAMHD1 and p21 in different HIV+ phenotypic groups. PATIENTS AND METHODS: We evaluated SAMHD1 and CDKN1A mRNA expression in CD4+ T cells from HIV+ individuals including elite controllers (n = 12), individuals who control HIV without the need for antiretroviral treatment, viraemic progressors (n = 10) and HIV-1 seronegative healthy donors (n = 14). Immunological variables were measured by flow cytometry.
RESULTS: We show that a subset of HIV+ elite controllers with lower T cell proliferation levels (Ki67+ cells) expressed higher SAMHD1 compared with healthy donors or viraemic progressors. Conversely, there was no difference in p21 expression before or after T cell activation with a bispecific CD3/CD8 antibody.
CONCLUSIONS: Our results suggest that SAMHD1 may play a role in controlling virus replication in HIV+ individuals and slow the rate of disease progression.
© The Author 2014. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  p21; restriction factors; viral control

Mesh:

Substances:

Year:  2014        PMID: 25063780     DOI: 10.1093/jac/dku276

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  16 in total

1.  Differential regulatory activities of viral protein X for anti-viral efficacy of nucleos(t)ide reverse transcriptase inhibitors in monocyte-derived macrophages and activated CD4(+) T cells.

Authors:  Joseph A Hollenbaugh; Susan M Schader; Raymond F Schinazi; Baek Kim
Journal:  Virology       Date:  2015-08-29       Impact factor: 3.616

2.  SAMHD1 expression in blood cells of HIV-1 elite suppressors and viraemic progressors.

Authors:  Erin L Buchanan; Melissa A McAlexander; Kenneth W Witwer
Journal:  J Antimicrob Chemother       Date:  2014-10-23       Impact factor: 5.790

3.  Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir.

Authors:  Edurne Garcia-Vidal; Marc Castellví; Maria Pujantell; Roger Badia; Antoni Jou; Lucia Gomez; Teresa Puig; Bonaventura Clotet; Ester Ballana; Eva Riveira-Muñoz; José A Esté
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

4.  Analysis of Immunological, Viral, Genetic, and Environmental Factors That Might Be Associated with Decreased Susceptibility to HIV Infection in Serodiscordant Couples in Florianópolis, Southern Brazil.

Authors:  Íris M Santos; Elis A da Rosa; Tiago Gräf; Luiz G E Ferreira; Andrea Petry; Fernanda Cavalheiro; Edna M Reiche; Carlos R Zanetti; Aguinaldo R Pinto
Journal:  AIDS Res Hum Retroviruses       Date:  2015-09-21       Impact factor: 2.205

5.  Stem-loop binding protein is a multifaceted cellular regulator of HIV-1 replication.

Authors:  Ming Li; Lynne D Tucker; John M Asara; Collins K Cheruiyot; Huafei Lu; Zhijin J Wu; Michael C Newstein; Mark S Dooner; Jennifer Friedman; Michelle A Lally; Bharat Ramratnam
Journal:  J Clin Invest       Date:  2016-07-25       Impact factor: 14.808

6.  Inhibition of herpes simplex virus type 1 by the CDK6 inhibitor PD-0332991 (palbociclib) through the control of SAMHD1.

Authors:  Roger Badia; Guillem Angulo; Eva Riveira-Muñoz; Maria Pujantell; Teresa Puig; Cristina Ramirez; Javier Torres-Torronteras; Ramón Martí; Eduardo Pauls; Bonaventura Clotet; Ester Ballana; José A Esté
Journal:  J Antimicrob Chemother       Date:  2015-11-04       Impact factor: 5.790

7.  Increased SAMHD1 transcript expression correlates with interferon-related genes in HIV-1-infected patients.

Authors:  Maura Statzu; Letizia Santinelli; Agnese Viscido; Claudia Pinacchio; Giancarlo Ceccarelli; Claudia Rotondo; Giuseppe Corano Scheri; Ivano Mezzaroma; Ombretta Turriziani; Guido Antonelli; Gabriella d'Ettorre; Carolina Scagnolari
Journal:  Med Microbiol Immunol       Date:  2018-12-18       Impact factor: 4.148

8.  Low SAMHD1 expression following T-cell activation and proliferation renders CD4+ T cells susceptible to HIV-1.

Authors:  Nicolas Ruffin; Vedran Brezar; Diana Ayinde; Cécile Lefebvre; Julian Schulze Zur Wiesch; Jan van Lunzen; Maximilian Bockhorn; Olivier Schwartz; Hakim Hocini; Jean-Daniel Lelievre; Jacques Banchereau; Yves Levy; Nabila Seddiki
Journal:  AIDS       Date:  2015-03-13       Impact factor: 4.177

9.  miRNAs and SAMHD1 regulation in vitro and in a model of HIV CNS disease.

Authors:  Kenneth W Witwer; Erin L Buchanan; Stephanie L Myers; Melissa A McAlexander
Journal:  J Neuroinflammation       Date:  2015-09-04       Impact factor: 8.322

10.  SAMHD1 transcript upregulation during SIV infection of the central nervous system does not associate with reduced viral load.

Authors:  Erin L Buchanan; Diego A Espinoza; Melissa A McAlexander; Stephanie L Myers; Adam Moyer; Kenneth W Witwer
Journal:  Sci Rep       Date:  2016-03-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.